Stock Market Stories and Insights

<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#347AFC;color: #ffffff;font-size:0.9em;;'>FLR</div>
  over a month ago at Macroaxis 
By Raphi Shpitalnik
Fluor is scheduled to announce its earnings tomorrow. Fluor Market Capitalization is relatively stable at the moment as compared to the past year. Fluor reported last year Market Capitalization of 4.08 Billion. As of 08/15/2020, Tangible Asset Value is likely to grow to about 9.8 B, while Invested Capital is likely to drop slightly above 4.9 B. While some of us are becoming more enthusiastic about industrials space, let's sum up Fluor in greater detail to make a better estimate of its debt utilization. We will evaluate why recent Fluor price moves suggest a bounce in September.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#4E8BFC;color: #ffffff;font-size:1.1em;;'>OM</div>
  over a month ago at Macroaxis 
By Raphi Shpitalnik
Given the investment horizon of 60 days, Odyssey Marine is expected to generate 2.69 times more return on investment than the market. However, the company is 2.69 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The DOW is currently generating roughly 0.14 per unit of risk. While many risk-averse investors are getting carried away by overanalyzing industrials space, it is reasonable to break down Odyssey Marine Exploration. We will go over odds for Odyssey Marine to generate above-average margins in two-three weeks.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#000000;color: #f2f2f2;font-size:1.1em;;'>MP</div>
  over a month ago at Macroaxis 
By Achuva Shats
As many rational traders are trying to avoid healthcare space, it makes sense to examine Merrimack Pharmaceuticals a little further and understand how it stands against DiaMedica Therapeutics and other similar entities. We are going to concentrate on some of the competitive aspects of both Merrimack and DiaMedica.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#8B008B;color: #ffffff;font-size:1.1em;;'>PC</div>
  over a month ago at Macroaxis 
By Ellen Johnson
It appears Party City will continue to recover much faster as its share price surged up 28.08% today. The firm's current daily volatility is 11.5 percent, with a beta of 0.33 and an alpha of 3.17 over DOW. While some baby boomers are getting worried about aggressive defence, it is reasonable to break down Party City Holdco. Why are we still confident in our projection for a recovery.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#82ADFD;color: #ffffff;font-size:1.1em;;'>BH</div>
  over a month ago at Macroaxis 
By Achuva Shats
As many millenniums are trying to avoid healthcare space, it makes sense to review Bellus Health a little further and try to understand its current market patterns. For many short-horizon oriented investors Bellus Health may not be the right move right now, but if you are here for the long run, it may be worthy of a closer look. The company returns are related to each other to returns on the market. As market swings up or down, the company is expected to follow. The indication of stable basic indicators of the firm implies a short-horizon price swing for private investors of Bellus. Bellus Health is scheduled to announce its earnings tomorrow. The next earnings report is expected on the 12th of November 2020. The stock is currently undergoing a sell-off trend.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#4E8BFC;color: #ffffff;font-size:1.1em;;'>MS</div>
  over a month ago at Macroaxis 
By Raphi Shpitalnik
It looks as if Madison Square may not recover as fast as we have hopped for as its price went down 1.78% today. The company's current daily volatility is 157.13 percent, with a beta of -19.42 and an alpha of 42.34 over DOW. While many traders are getting carried away by overanalyzing market volatility, it is reasonable to digest Madison Square Garden based on how it reacts to the latest economic swings. We will analyze why it could be a much better year for Madison Square shareholders.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#347AFC;color: #ffffff;font-size:1.1em;;'>EN</div>
  over a month ago at Macroaxis 
By Vlad Skutelnik
While many traders are getting carried away by overanalyzing energy space, it is reasonable to focus on Enservco. Why are we still confident in anticipation of a complete recovery. Is the firm operations in 2020 sustainable? Here we are going to cover Enservco perspective on valuation to give you a better outlook on taking a position in this stock.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#4E8BFC;color: #ffffff;font-size:1.1em;;'>SS</div>
  over a month ago at Macroaxis 
By Gabriel Shpitalnik
The underlying reasoning behind this short post is to sum up Sky Solar as an investment oportunity for September. We will discuss why recent Sky Solar price moves suggest a bounce in September.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#008000;color: #f8f8f8;font-size:1.1em;;'>BK</div>
  over a month ago at Macroaxis 
By Vlad Skutelnik
In general, we focus on analyzing BIO Key (NASDAQ:BKYI) price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BIO Key International daily price indicators and compare them against related drivers. Let's try to concentrate on what's happening with BIO Key amid unprecedented political, and economic uncertainty.
<div class='circular--portrait-small' style='padding: 0px; text-align: center; font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:0.9em;;'>OCG</div>
  over a month ago at Macroaxis 
By Raphi Shpitalnik
It seems Ocugen will continue to recover much faster as its share price surged up 3.33% today. The firm's current daily volatility is 14.9 percent, with a beta of 0.07 and an alpha of 1.77 over DOW. As many millenniums are trying to avoid pharmaceutical products, it makes sense to outline Ocugen Inc a little further and try to understand its current market patterns. We will analyze why Ocugen investors may still consider a stake in the business.